Markers of vascular damage depending on the blood pressure level: data of the population study ESSE-RF
https://doi.org/10.15829/1560-4071-2020-3652
Abstract
Aim. To evaluate the relationship of prehypertension (preHTN) with vascular wall damage and decreased renal function depending on cardiovascular risk in a representative sample of Russian population.
Material and methods. As a part the ESSE-RF study in 4 regions (St. Petersburg, Tomsk, Tyumen, the Republic of North Ossetia), 7042 participants aged 25-64 were additionally examined for state of vessels. All participants signed informed consent and completed the approved questionnaires. Anthropometry, fasting glucose and blood pressure (BP) levels were assessed. BP was measured by the OMRON monitor (Japan) twice on the right hand in a sitting position; average BP was calculated. The optimal BP was considered <120/80 mm Hg, preHTN — 120-139/80-89 mm Hg, HTN — ≥140/90 mm Hg or antihypertensive therapy. The 10-year risk of fatal cardiovascular diseases was determined according to the SCORE charts. Glomerular filtration rate (GFR) was calculated using the CKD-EPI equation. Investigation of vessels was performed using a vascular screening system VaSera, Fukuda Denshi. Cardio-ankle vascular index (CAVI) and ankle-brachial index (ABI) was determined. Statistical analysis was performed using SPSS Statistics 20.
Results. The analysis included data of 6906 participants, among which women predominated (n=4531; 65,6%). An increase in the prevalence of subclinical vascular lesion according to CAVI was detected with a BP increase from optimal to preHTN and HTN (0,06, 0,19 and 0,75, respectively). According to ABI, this pattern was not observed (0,24, 0,22 and 0,54, respectively). The prevalence of ABI <0,9 was greatest in the HTN group and did not significantly differ between patients with preHTN and optimal BP. After the exclusion of 1610 patients belonging to the groups of high and very high cardiovascular risk, the prevalence of subclinical vascular lesion was reevaluated. With a BP increase from optimal to preHTN and HTN in the low-risk groups of cardiovascular events, an increase in the prevalence of subclinical vascular lesions was also observed only according to CAVI (0,11, 0,28 and 0,62, respectively). Due to the low prevalence of chronic kidney disease (CKD) in the general population (n=7), the analysis of CKD prevalence in groups by BP level was not carried out. According to linear regression analysis (adjusted for sex, age, body mass index, total cholesterol level), significant associations of systolic BP with GFR, CAVI, and ABI were not detected in the groups of optimal BP, preHTN, and HTN.
Conclusion. Regardless of cardiovascular risk grade, an increase in the prevalence of subclinical vascular lesions was detected with an increase in BP from optimal to preHTN and HTN only according to CAVI. The prevalence of decreased ABI did not significantly differ between patients with preHTN and optimal BP. No association of GFR reduction with preHTN has been identified.
About the Authors
A. M. ErinaRussian Federation
St. Petersburg
M. A. Boyarinova
Russian Federation
St. Petersburg
E. V. Moguchaya
Russian Federation
St. Petersburg
E. P. Kolesova
Russian Federation
St. Petersburg
A. S. Aliyeva
Russian Federation
St. Petersburg
O. P. Rotar
Russian Federation
St. Petersburg
E. I. Baranova
Russian Federation
St. Petersburg
S. A. Shalnova
Russian Federation
Moscow
A. D. Deev
Russian Federation
Moscow
Z. T. Astakhova
Russian Federation
Vladikavkaz
L. Z. Bolieva
Russian Federation
Vladikavkaz
G. V. Tolparov
Russian Federation
Beslan
V. S. Kaveshnikov
Russian Federation
Tomsk
V. N. Serebryakova
Russian Federation
Tomsk
I. A. Trubacheva
Russian Federation
Tomsk
R. S. Karpov
Russian Federation
Tomsk
A. Yu. Efanov
Russian Federation
Tyumen
M. A. Storozhok
Russian Federation
Tyumen
I. V. Medvedeva
Russian Federation
Tyumen
S. V. Shalaev
Russian Federation
Tyumen
A. N. Rogoza
Russian Federation
Moscow
A. O. Konradi
St. Petersburg
S. A. Boytsov
Russian Federation
Moscow
E. V. Shlyakhto
Russian Federation
St. Petersburg
References
1. Chobanian AV, Bakris GL, Black HR, et al. National High Blood Pressu re Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-72. doi:10.1001/jama.289.19.2560.
2. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;14;360(9349):1903-13. doi:10.1016/s0140-6736(02)11911-8.
3. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med. 2004;164:2113-8. doi:10.1001/archinte.164.19.2113.
4. Qureshi AI, Suri MF, Kirmani JF, et al. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005;36:1859-63. doi:10.1161/01.STR.0000177495.45580.f1.
5. Hsia J, Margolis KL, Eaton CB, et al. Prehypertension and cardiovascular disease risk in the Women’s Health Initiative. Circulation. 2007;115:855-60. doi:10.1161/CIRCULATIONAHA.106.656850.
6. Garofalo C, Borrelli S, Pacilio M, et al. Hypertension and Prehypertension and Prediction of Development of Decreased Estimated GFR in the General Population: A Meta-analysis of Cohort Studies. Am J Kidney Dis. 2016;67(1):89-97. doi:10.1053/j.ajkd.2015.08.027.
7. Huang Y, Cai X, Zhang J, et al. Prehypertension and Incidence of ESRD: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63(1):76-83. doi:10.1053/j.ajkd.2013.07.024.
8. Rubio-Guerra AF, Garro-Almendaro AK, Lozano-Nuevo JJ, et al. Prehypertension is associated with peripheral arterial disease and low ankle-brachial index. Indian Heart J. 2018;70(4):502-5. doi:10.1016/j.ihj.2017.11.013.
9. Thitiwuthikiat P, Siriwittayawan D, Nuamchit T, et al. Prehypertension and high serum uric acid increase risk of arterial stiffness Scand. J. Clin. Lab. Invest. 2017;77(8):673-8. doi:10.1080/00365513.2017.1397287.
10. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357. doi:10.1097/01.hjh.0000431740.32696.cc.
11. Рогоза А.Н., Кавешников В.С., Трубачева И.А. и др. Состояние сосудистой стенки в популяции взрослого населения на примере жителей города Томска по данным исследования ЭССЕ-РФ. Системные гипертензии. 2014;4:42-8.
12. Meigs JB, Hu FB, Rifai N, et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291, 1978-1986 (2004). doi:10.1001/jama.291.16.1978.
13. Khosravani A, Emamia MH, Hashemi H, et al. Pre-hypertension and the risk of diabetes mellitus incidence using a marginal structural model in an Iranian prospective cohort study. Epidemiol. Health 2018;40(0):e2018026-0. doi:10.1016/S0140-6736(11)61349-4.
14. Huang Y, Xiaoya C, Chaghua L, et al. Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis. J. Am. Heart Assoc. 2015;19,4(2). doi:10.1161/JAHA.114.001519.
15. Huang Y, Cai X, Li Y, et al. Prehypertension and the risk of stroke: A meta-analysis. Neurology. 2014;82(13):1153-61. doi:10.1212/WNL.0000000000000268.
Review
For citations:
Erina A.M., Boyarinova M.A., Moguchaya E.V., Kolesova E.P., Aliyeva A.S., Rotar O.P., Baranova E.I., Shalnova S.A., Deev A.D., Astakhova Z.T., Bolieva L.Z., Tolparov G.V., Kaveshnikov V.S., Serebryakova V.N., Trubacheva I.A., Karpov R.S., Efanov A.Yu., Storozhok M.A., Medvedeva I.V., Shalaev S.V., Rogoza A.N., Konradi A.O., Boytsov S.A., Shlyakhto E.V. Markers of vascular damage depending on the blood pressure level: data of the population study ESSE-RF. Russian Journal of Cardiology. 2020;25(6):3652. https://doi.org/10.15829/1560-4071-2020-3652